Deal watch: Roche deal targets glutamate in neurodevelopmental disorders.Published in:Nature Reviews Drug Discovery, 2012, v. 11, n. 8, p. 590, doi. 10.1038/nrd3808By:Harrison, CharlottePublication type:Article